King Charles III's ongoing cancer treatment is set to extend into 2025, as confirmed by Fox News Digital. Despite the ongoing health challenge, sources indicate a positive trajectory in his battle against the undisclosed form of cancer, first revealed earlier this year. People magazine reports that the King's condition is being effectively managed.
A Buckingham Palace insider informed People that Charles' treatment will continue into the new year, characterizing it as a "managed condition." The 76-year-old monarch is determined to maintain his public duties, with planned engagements both within the U.K. and internationally in 2025.
The specific nature of King Charles' treatment remains undisclosed. However, Dame Laura Lee, CEO of the cancer support charity Maggie's, of which Queen Camilla is a patron, has offered context. She explained to Sky News that extended treatment periods are common, citing the Princess of Wales' experience with a year-long intensive treatment regimen. Lee emphasized the variety of cancer treatment approaches, including immunotherapy, chemotherapy, surgery, and hormone therapy, suggesting that the King's ongoing treatment is not unusual.
As the holiday season approaches, King Charles and Queen Camilla are preparing for Christmas at Sandringham estate in Norfolk. Before their holiday retreat, the royal couple will fulfill their final public engagements, including meetings with community volunteers and faith representatives.
The King's cancer diagnosis was initially announced in February by Buckingham Palace following a procedure for benign prostate enlargement. After a brief hiatus, he resumed his royal duties in April. The same year also saw the Princess of Wales face her own cancer diagnosis, initially believed to be non-cancerous following abdominal surgery, but later confirmed and treated with chemotherapy.
Prince William recently reflected on the challenges of 2024, describing it as a "brutal" and "hardest year" during a visit to Cape Town, South Africa. He expressed pride in his wife and father for their resilience in the face of personal and public trials.
